Stock 2487 CUTIA THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Company Cutia Therapeutics

Equities

2487

KYG2606C1006

Pharmaceuticals

Delayed Hong Kong S.E.
Other stock markets
 10:28:33 2024-05-20 pm EDT 		5-day change 1st Jan Change
7.62 HKD -1.04% Intraday chart for Cutia Therapeutics +7.78% -30.60%
Apr. 30 Cutia Therapeutics' Unit Receives Jiangsu Drug Manufacturing Certificate MT
Apr. 30 Cutia Therapeutics Submits NDA for Androgenetic Alopecia Treatment Spray; Shares Jump 6% MT

Business Summary

Cutia Therapeutics is a China-based company mainly engaged in the research and development and manufacture of dermatological biological drugs. The Company is committed to developing comprehensive solutions to meet the diverse needs of patients and consumers in a wide range of dermatological treatment and care markets. The Company is mainly engaged in clinical trials of its core product CU-20401. This product is mainly used to treat submental fat accumulation. The Company conducts its businesses in the domestic market and overseas markets.

Number of employees: 298

Sales per Business

HKD in Million2022Weight2023Weight Delta
Dermatology Treatment and Care
100.0 %
- - 152 100.0 % -

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
13 100.0 % 152 100.0 % +1,050.56%

Managers

Managers TitleAgeSince
Le Le Zhang FOU
 Founder 46 19-05-14
Yu Qing Huang DFI
 Director of Finance/CFO 34 21-05-09
Lei Lei CTO
 Chief Tech/Sci/R&D Officer 40 20-01-09
Qi Zhu CTO
 Chief Tech/Sci/R&D Officer 52 19-09-08
Jia Ru Wu PRN
 Corporate Officer/Principal 41 19-08-04
Jing Xin Xu PRN
 Corporate Officer/Principal 46 20-11-30
Chun Na Zhang LAW
 General Counsel 46 19-10-09
Sze Ting Chan SEC
 Corporate Secretary 42 22-11-14

Members of the board

Members of the board TitleAgeSince
Tak Yan Tao BRD
 Director/Board Member 48 23-05-31
Lian Yong Chen CHM
 Chairman 62 19-08-22
Ming Kit Chung BRD
 Director/Board Member 46 23-06-11
Qin Xie BRD
 Director/Board Member 44 19-08-22
Yun Xia Yang BRD
 Director/Board Member 51 20-08-25
Le Le Zhang FOU
 Founder 46 19-05-14
Xiao Huang BRD
 Director/Board Member 39 20-08-25
Yu Qing Huang DFI
 Director of Finance/CFO 34 21-05-09
Xiao Xiang Ye BRD
 Director/Board Member 50 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 304,738,625 247,242,580 ( 81.13 %) 0 81.13 %

Shareholders

NameEquities%Valuation
6 Dimensions Capital
20.27 %
61,771,710 20.27 % 58 M $
Aurora Cutis Esp
17.73 %
54,019,020 17.73 % 51 M $
Feng Yu
13.13 %
40,000,000 13.13 % 37 M $
Suzhou Yunchang Investment Consulting Co. Ltd.
8.511 %
25,935,425 8.511 % 24 M $
Hongshan
8.438 %
25,714,285 8.438 % 24 M $
FIL Investment Management (Hong Kong) Ltd.
4.656 %
14,187,980 4.656 % 13 M $
Harvest Global Investments Ltd.
2.349 %
7,158,600 2.349 % 7 M $
FIL Investment Management (Singapore) Ltd.
2.297 %
6,999,845 2.297 % 7 M $
Nan Peng Shen
2.250 %
6,857,143 2.250 % 6 M $
Wuxi Heyuan
0.2584 %
787,400 0.2584 % 736 943 $

Company contact information

Cutia Therapeutics

Huanzhi Building 436 Heng Feng Road

200070, Shanghai

+

http://www.cutiatx.com
address Cutia Therapeutics(2487)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Cutia Therapeutics

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.143 CNY
Average target price
16.85 CNY
Spread / Average Target
+135.92%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CUTIA THERAPEUTICS Stock Cutia Therapeutics
-29.87% 287M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+34.35% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.49% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.15% 332B
ABBVIE INC. Stock AbbVie Inc.
+6.19% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.11% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+9.21% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 2487 Stock
  4. Company Cutia Therapeutics
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW